Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations Between Sleep and Adolescent Mental Health Before and During the COVID-19 Pandemic in a Partial Hospitalization Program.

JAACAP open·2026
Same author

National Institute on Drug Abuse (NIDA) clinical trials network (CTN) stimulant use disorder (StUD) task force results: 2024 update.

Journal of substance use and addiction treatment·2026
Same author

Validation of the Brief Children's Depression Rating Scale in Children Treated With Selegiline Transdermal Patch vs Placebo.

JAACAP open·2026
Same author

Defining anhedonia subgroups using the dimensional anhedonia rating scale in active depression: Findings from the Texas resilience against depression study.

Journal of psychiatric research·2025
Same author

Use of a Medication Management Algorithm in Depressed Youth Living with HIV: Secondary Analysis of a Multisite Randomized Controlled Trial.

Journal of child and adolescent psychopharmacology·2025
Same author

Side effect profile and comparative tolerability of newer generation antidepressants in the acute treatment of major depressive disorder in children and adolescents: protocol for a systematic review and network meta-analysis.

BMJ open·2025
Same journal

Reimagining the Behavioral Health Crisis Care Continuum for Youth.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Addressing the Behavioral Health Needs of Special Populations Within the Youth Crisis Care Continuum.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Technology-Enabled Crisis Care for Youth: Bridging the Gap.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Crisis Phone Services.

Child and adolescent psychiatric clinics of North America·2026
Same journal

A Crisis Care Continuum for Children and Adolescents: The Boston Medical Center Model.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Mobile Response and Stabilization Services.

Child and adolescent psychiatric clinics of North America·2026
See all related articles

Related Experiment Video

Updated: May 18, 2026

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

Depression.

Christine J Choe1, Graham J Emslie, Taryn L Mayes

  • 1Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390-8589, USA. christine.choe@utsouthwestern.edu

Child and Adolescent Psychiatric Clinics of North America
|October 9, 2012
PubMed
Summary
This summary is machine-generated.

This review covers evidence-based depression treatments for youth, highlighting personalized care and pharmacologic strategies. Further research is needed for non-SSRI antidepressants and comorbid conditions in depressed children and adolescents.

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Related Experiment Videos

Last Updated: May 18, 2026

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Area of Science:

  • Child and Adolescent Psychiatry
  • Clinical Psychology
  • Pharmacology

Background:

  • Depression in children and adolescents requires effective assessment and treatment strategies.
  • Evidence-based treatments are crucial for improving clinical care outcomes.
  • Existing research guides but does not fully personalize treatment decisions.

Purpose of the Study:

  • To review current assessment and treatment of pediatric depression.
  • To emphasize the implementation of evidence-based interventions.
  • To discuss pharmacologic options for complex cases.

Main Methods:

  • Review of past antidepressant medication trials.
  • Analysis of clinical use of antidepressants in youth.
  • Examination of pharmacologic strategies for refractory or comorbid depression.

Main Results:

  • A body of empirical research now exists to guide clinicians.
  • Personalized treatment considering symptoms, comorbidities, and history is essential.
  • Current evidence supports specific pharmacologic approaches but highlights gaps.

Conclusions:

  • Clinicians have resources for treating youth depression, but personalization is key.
  • Further research is needed on non-SSRI antidepressants and augmentation strategies.
  • Investigating treatment for depressed youth with comorbid conditions is critical.